Companion Diagnostics Market Scenario
Rising need for targeted therapy, technological advancements in the field of companion diagnostics and increasing importance of personalized medicine are some of the major factors propelling the companion diagnostics market globally. Furthermore, growing burden of infectious diseases is also one of the factor propelling the growth of companion diagnostics market. However, high cost of companion diagnostic tests is one of the major factor expected to hamper the global growth of the market.
Companion Diagnostics Market Segmentation
The Companion Diagnostics market is segmented by Products & Services, Technology, Indication, End User and Geography. The Products & Services studied in the report are Assay kits & Reagents and Software & Services. Furthermore, the Technology comprises of Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC) and others. Moreover, the Indication include Cardiovascular, Neurological Diseases, Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma and Gastric Cancer), Infectious Diseases and Others. In addition, various End Users of companion diagnostics market are Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs and Others. Based on Geography, the Companion Diagnostics Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Companion Diagnostics Market by Geography
Based on geography, the Companion Diagnostics market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global Companion Diagnostics market. Major drivers include high adoption of advanced techniques and diagnostic tools, higher healthcare expenditure, and availability of skilled professionals. U.S. holds the largest market share owing to factors such as highly developed healthcare infrastructure and availability of skilled professionals.
Companion Diagnostics Market Key Players
Some of the major players operating in the global Companion Diagnostics market includes F. Hoffmann-La Roche Ag, Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Almac Group, Danaher Corporation, Illumina Inc., Biomérieux Sa, Myriad Genetics, Inc., Sysmex Corporation, Abnova Corporation, Guardant Health, Inc., Icon Plc and Biogenex Laboratories, Inc. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.
Companion Diagnostics Market Report Key Benefits